Delighted to announce Endologix ranked 14th among the Top 25 Medical Device companies in 2024! Guided by data, we pioneer interventions that address persistent unmet needs in patients with vascular disease. #MedicalDevice #TopRanking #embracetheevidence Learn more about the Top 25 Medical Device Companies award: https://lnkd.in/g_hiWndj
关于我们
Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. We have a therapeutic portfolio designed to treat diseases which currently have clinically relevant unmet needs. Our existing products can treat a wide spectrum of vascular disease through abdominal aortic aneurysms to lower limb peripheral vascular disease. We obtain excellent clinical outcomes through meticulous attention to product design, manufacturing, and training, all backed by industry-leading clinical evidence. With a robust pipeline of disruptive technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well-being, we are never satisfied with the status quo.
- 网站
-
https://www.endologix.com
Endologix LLC的外部链接
- 所属行业
- 医疗设备
- 规模
- 501-1,000 人
- 总部
- Irvine，CA
- 类型
- 私人持股
- 创立
- 1992
- 领域
- EVAR、AAA、Aneurysms、Endovascular、Engineering、Regulatory Affairs、Manufacturing、Supply Chain、Research & Development和medical device
地点
Endologix LLC员工
动态
-
Beyond the numbers, 1,000 cases for #PTAB with the #DETOURSystem means we're increasing patient access to this alternative to open surgical bypass. This is the true accomplishment we want to celebrate, and it wouldn't have been possible without the entire Endologix team. Thank you all for your dedication to improving the lives of patients with vascular disease!
-
-
Exceptional Female Anatomy Deserves an Exceptional Approach to EVAR - Learn more about ALTO: https://lnkd.in/gMdHsAJQ #AAA #vascsurg #EVAR ISI: https://lnkd.in/gvXdfxd3
-
-
1,000 patients and counting! Endologix celebrates major milestone for the DETOUR System, bringing new possibilities to #PAD treatment. Read more here https://lnkd.in/gyQ8kHFw #DETOURSystem #PioneeringForPatients
-
-
Congratulations, Dr. Sheraz Qureshi, for making Endologix history, having treated patient 1,000 for #PTAB with the #DETOURSystem. The case images are clear - DETOUR makes it possible to bypass long lesions in the #SFA using stents routed through the femoral vein to restore blood flow. Learn about the DETOUR System: https://lnkd.in/geiZmcEX Northwestern Medicine
-
-
We are proud to partner with Sabeen Dhand, MD, on his first #PTAB case with the #DETOURSystem (the first in all of Los Angeles County!). Congratulations for giving patients with long complex #SFA disease another option. ???????????? Learn more about the DETOUR System here https://buff.ly/0ExKkEF PIH Health, BackTable Vascular and Interventional
-
-
?? Breaking news! On Friday, March 14, we reached 1,000 cases for #PTAB with the #DETOURSystem! Congratulations to all the physicians who contributed to this incredible achievement! We appreciate your partnership. This is only the beginning - we look forward to helping more patients with complex PAD gain access to this novel therapy! Learn more about the DETOUR System here https://buff.ly/0Cw7u19
-
-
Congratulations to Dr. Laiq Raja and the Cath Lab team from The Hospitals of Providence Memorial Campus on the completion of their first PTAB with the DETOUR System procedure! Endologix is proud to partner with physicians to deliver innovative therapies that improve the lives of patients with vascular disease. Learn more about the DETOUR System here https://lnkd.in/geiZmcEX #PAD #PTAB #DETOURSystem
The Memorial Campus is excited to be the first hospital in El Paso to offer the DETOUR System, a new treatment option for patients with complex Peripheral Artery Disease (PAD). We are proud to bring this innovative technology to our community and look forward to helping patients with complex PAD. Congratulations to Dr. Laiq Raja, Interventional Cardiologist, and the Cath Lab team on a successful first procedure and for advancing heart care for our community.
-
-
Patients with lesions from 20-46cm may be eligible for PTAB. Let's take a closer look into a patient who has been treated with the DETOUR System. This patient presented with a chronic total occlusion in the left SFA and physicians chose to treat with PTAB using the DETOUR System. What would your treatment pathway be for a patient like this one? Tell us your thoughts below! Want to see more cases? Click here: https://lnkd.in/g7PQezzX #PTAB #DETOURSystem #SFA #PeripheralArteryDisease ISI: https://lnkd.in/g59C8vWd
-
-
This week, 5 new team members participated in an intensive ALTO and AFX2 training workshop, gaining valuable insights into our innovative EVAR solutions. At Endologix, we are committed to equipping our teams with the knowledge and expertise needed to advance patient care and clinical outcomes. Their dedication will help drive our mission of pioneering life-saving solutions for patients with vascular disease. #PioneeringForPatients #EVAR #ALTO #AFX2 #MedicalInnovation
-